Comparison of insulin detemir and insulin glargine in subjects with Type 1 diabetes using intensive insulin therapy

Diabetic Medicine - Tập 24 Số 6 - Trang 635-642 - 2007
Thomas R. Pieber1, H‐C. Treichel1, B. Hompesch2, Areti Philotheou3, L. Mordhorst4, M‐A. Gall4, London Robertson5
1Leopold Auenbrugger Medical University, Graz, Austria, Johanniter Hospital, Genthin and
2Profil Outpatient Trials GmbH, Neuss, Germany
3UCT Medical School, Cape Town, South Africa,
4Novo Nordisk, Sorgenfri, Denmark and
5Parklands Medical Centre, Durban, South Africa

Tóm tắt

AbstractAims  To compare glycaemic control and risk of hypoglycaemia of twice‐daily insulin detemir with once‐daily insulin glargine in subjects with Type 1 diabetes.Methods  In this 26‐week, multicentre, open‐label, parallel‐group trial, 320 subjects with Type 1 diabetes received either insulin detemir twice daily or insulin glargine once daily. each in combination with premeal insulin aspart.Results  After 26 weeks, HbA1c had decreased from 8.8 to 8.2% in the insulin detemir group and from 8.7 to 8.2% in the insulin glargine group. Home‐measured fasting plasma glucose (PG) was lower with insulin glargine than with insulin detemir (7.0 vs. 7.7 mmol/l, P < 0.001). The overall shape of the home‐measured nine‐point PG profiles was comparable between treatments (P = 0.125). Overall, there was no significant difference in within‐subject variation in PG (P = 0.437). Within‐subject variation in predinner PG was lower with insulin detemir than with insulin glargine (P < 0.05). The overall risk of hypoglycaemia was similar with no differences in confirmed hypoglycaemia. However, the risk of severe and nocturnal hypoglycaemia was 72% and 32%, respectively, lower with insulin detemir than with insulin glargine (P < 0.05). Body weight gain was not significantly different comparing insulin detemir and insulin glargine (0.52 kg vs. 0.96 kg, P = 0.193).Conclusions  Treatment with twice‐daily insulin detemir or once‐daily insulin glargine, each in combination with insulin aspart, resulted in similar glycaemic control. The overall risk of hypoglycaemia was comparable, whereas the risks of both severe and nocturnal hypoglycaemia were significantly lower with insulin detemir.

Từ khóa


Tài liệu tham khảo

Diabetes‐Control ACTRG., 1993, The effect of intensive treatment of diabetes on the development and progression of long‐term complications in insulin‐dependent diabetes mellitus, New Engl J Med, 329, 977, 10.1056/NEJM199309303291401

10.1111/j.1600-051X.1988.tb01003.x

10.1001/archinte.158.2.134

10.1016/0168-8227(95)01064-K

10.1056/NEJM199307293290502

10.1016/S0140-6736(98)12459-5

10.1055/s-2007-1018694

10.1042/bj3120725

10.1023/B:PHAM.0000036926.54824.37

10.1016/S0149-2918(03)80156-X

10.2337/diacare.28.5.1107

10.2337/diacare.23.5.644

10.1111/j.1463-1326.2004.00363.x

10.2337/diacare.23.2.157

10.2337/diacare.24.2.296

10.2337/diacare.27.5.1081

10.1016/S0149-2918(04)90072-0

10.2337/diacare.26.3.590

10.1111/j.1464-5491.2005.01545.x

10.1089/dia.2004.6.579

10.2337/diabetes.53.6.1614

10.2337/diacare.23.5.639

10.2337/diacare.23.8.1137

10.2337/diacare.26.5.1490

Lantus European Public Assessment Report.Available athttp://wwwemeaeuint/humandocs/Humans/EPAR/lantus/lantushtm 2005. Last accessed September 2006.

10.1055/s-0029-1211985

10.1007/s00125-004-1365-z

10.2337/diacare.26.2007.S33

10.2337/diacare.27.2.632

10.1016/j.diabres.2004.02.008

10.1111/j.1464-5491.2004.01323.x

10.1111/j.1464-5491.2005.01781.x

10.1111/j.1464-5491.2006.01862.x

10.1016/j.diabres.2004.03.003

McCrimmon RJ, 1994, Hypoglycaemia, the most feared complication of insulin therapy, Diabetes Metab, 20, 503

Thông tin
Thông tin xuất bản

Diabetic Medicine

Tập 24 Số 6

635-642

Thông tin tác giả